32 Participants Needed

Surgery With/Without Nerve Cutting for Wrist Ganglion

Recruiting at 1 trial location
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Kenneth Taylor, M.D.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of this treatment for wrist ganglion?

Research shows that after surgery to remove a wrist ganglion, patients often experience less pain, better wrist movement, and improved grip strength. These improvements were seen in studies where patients were followed for several months after the procedure.12345

Is surgery for dorsal wrist ganglion safe?

Surgery to remove a dorsal wrist ganglion is generally safe, with studies showing no surgical complications or recurrences. Patients often experience improvements in wrist pain, range of motion, and grip strength after the procedure.12346

How does the treatment of dorsal wrist ganglion with or without nerve cutting differ from other treatments?

This treatment is unique because it involves the option of cutting a nerve (PIN) during surgery, which may help reduce pain or recurrence, unlike standard excision methods that do not address nerve involvement.12345

What is the purpose of this trial?

The purpose of this study is to determine if a statistical significance exists between outcomes of patients treated for dorsal wrist ganglion cyst with excision alone versus excision and the addition of a partial wrist denervation by resecting the common terminal sensory branch of the PIN (posterior interosseus nerve). Our hypothesis is that addition of PIN improves outcome after dorsal wrist ganglion excision as indicated by post-operative pain, function, ability to perform activities of daily living, and physical exam findings.

Research Team

KT

Kenneth Taylor, MD

Principal Investigator

Penn State Health Milton S Hershey Medical Center

Eligibility Criteria

This trial is for adults over 18 with painful dorsal wrist ganglion cysts affecting daily activities. Candidates must speak and understand English, be non-prisoners, able to follow the study plan, and have chosen surgery for their condition. It excludes those under 18, non-English speakers, prisoners, cognitively impaired individuals, anyone with prior wrist surgery or chronic instability in the affected wrist, neurological issues in that wrist, or who are pregnant.

Inclusion Criteria

Fluent in written and spoken English
I have chosen surgery to treat my ganglion cyst.
I understand the study and agree to follow all its procedures and visits.
See 4 more

Exclusion Criteria

Prisoners
I have had wrist surgery on one or both of my arms.
I have nerve-related health issues in the limb that needs surgery.
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Surgery

Participants undergo dorsal wrist ganglion excision with or without partial wrist denervation

1 day
1 visit (in-person)

Post-operative Monitoring

Participants are monitored post-operatively with surveys and physical examinations

12 months
Visits at 2 weeks, 12 weeks, 6 months, and 1 year

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Dorsal wrist ganglion alone (DWG)
  • DWG/PIN
Trial Overview The study compares two surgical methods for treating dorsal wrist ganglions: excision alone (DWG) versus excision plus partial denervation by cutting a sensory nerve branch (DWG/PIN). The goal is to see if adding nerve resection improves pain relief and function post-surgery.
Participant Groups
2Treatment groups
Active Control
Group I: Dorsal wrist ganglion alone (DWG)Active Control1 Intervention
Dorsal wrist ganglion excision alone
Group II: DWG with PINActive Control1 Intervention
Dorsal wrist ganglion excision with posterior interosseus neurectomy (PIN)

Find a Clinic Near You

Who Is Running the Clinical Trial?

Kenneth Taylor, M.D.

Lead Sponsor

Trials
3
Recruited
90+

References

Immobilization of the Wrist After Dorsal Wrist Ganglion Excision: A Systematic Review and Survey of Current Practice. [2023]
Arthroscopic resection of dorsal wrist ganglia: 114 cases with minimum follow-up of 2 years. [2022]
Arthroscopic dorsal wrist ganglion excision with color-aided visualization of the stalk: minimum 1-year follow-up. [2022]
Prospective Evaluation of Push-up Performance and Patient-Reported Outcomes Following Open Dorsal Wrist Ganglion Excision in the Active-Duty Military Population. [2023]
Two-Year Clinical Outcomes after Arthroscopic Re-Excision of Recurrent Dorsal Wrist Ganglion Cyst. [2023]
Epidemiology of Symptomatic Dorsal Wrist Ganglia in Active Duty Military and Civilian Populations. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security